Comparison of acute kidney injury between ABO‐compatible and ABO‐incompatible living donor liver transplantation: A propensity matching analysis

In‐Gu Jun, Byungdoo Lee, Seon‐Ok Kim, Won‐Jung Shin, Ji‐Youn Bang, Jun‐Gol Song, Gi‐Won Song, Sung‐Gyu Lee, Gyu‐Sam Hwang – 6 September 2016 – The anti‐CD20 monoclonal antibody rituximab has significantly decreased the prevalence of antibody‐mediated rejection of ABO‐incompatible (ABOi) living donor liver transplantation (LDLT). However, little is known about acute kidney injury (AKI) following ABOi LDLT. The aim of this study was to identify the incidence of AKI in ABOi LDLT and compare it with that of ABO‐compatible (ABOc) LDLT.

Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?

Suman Verma, Fiona Hand, Matthew J. Armstrong, Marie Vos, Douglas Thorburn, Terry Pan, John Klinck, Rachel H. Westbrook, Georg Auzinger, Andrew Bathgate, Steven Masson, Andrew Holt, Diarmaid D. Houlihan, James W. Ferguson – 4 September 2016 – Liver transplantation (LT) in patients with portopulmonary hypertension (PoPH) has historically resulted in unpredictable and often poor outcomes. The United Kingdom experience for the period 1992‐2012 is reported in this article.

Subscribe to